How much does apixaban really cost?

Prescription Costs at the Pharmacy Counter

Out‑of‑pocket costs for apixaban vary a lot. Brand Eliquis can cost hundreds of dollars a month without insurance, while generic apixaban — when available at discount prices — often runs about $1.08–$1.50 per tablet and can be even cheaper with 60‑ or 90‑day mail‑order fills. Commercial insurance and manufacturer copay cards can cut monthly costs to relatively low amounts, though Medicare and Medicaid have limits on those savings. Manufacturer assistance programs and coupons may help people without coverage. If you want plan‑specific numbers, pharmacy options, and step‑by‑step ways to save, see the practical guidance below.

Key Takeaways

  • Brand Eliquis typically costs much more than generic apixaban, often over $6 per 5 mg tablet at retail.

  • Generic apixaban commonly runs about $1.08–$1.50 per tablet, with lower per‑tablet prices on 60‑ or 90‑day or mail‑order fills.

  • With commercial insurance, typical out‑of‑pocket is roughly $20–$37 per month; Medicare averages about $51 per month.

  • Manufacturer copay cards can reduce costs for many people with commercial plans (for example, to a $10 copay) but usually don’t apply to Medicare or Medicaid.

  • Assistance programs, mail‑order 90‑day supplies, and coupon services can reduce or eliminate costs for eligible patients.

Typical Retail Prices for Apixaban: Brand Vs Generic

How much you pay depends largely on whether your prescription is for brand‑name Eliquis or a generic. Brand prices frequently exceed $6 per 5 mg tablet (about $388 for a 28‑tablet supply), while generic cash prices commonly fall in the $1.08–$1.50 per‑tablet range and drop further with 60‑tablet or mail‑order purchases. Retail pricing shows a clear brand‑name premium: Eliquis usually costs substantially more at standard retail pharmacies, though manufacturer savings programs can sometimes reduce out‑of‑pocket spending for eligible patients. Generic apixaban — and discount programs that mimic generic pricing — offer much lower cash prices and benefit from bulk and mail‑order discounts. Compare pharmacy quotes and consider larger supplies to lower your per‑tablet cost, and watch for program exclusions when evaluating assistance offers.

How Insurance, Medicare, and Copay Cards Affect Your Cost

Insurance type strongly affects what you pay. Commercial plans often bring monthly Eliquis costs down to about $37 (half of patients pay $20 or less). Medicare averages around $51 per month (half pay $30 or less) and can be reduced further by the Low‑Income Subsidy or Extra Help to as little as $0–$12.65. Manufacturer copay cards can substantially lower costs for many people with commercial coverage but are generally not accepted for Medicare Part D, Medicaid, or other government plans. Final out‑of‑pocket amounts depend on plan formularies, prior authorization rules, and the pharmacy you choose. Verify your benefits, check eligibility for subsidies like Low‑Income Subsidy or Extra Help, and confirm any savings with your insurer or by calling 1‑855‑ELIQUIS.

Pharmacy Options: Retail, Mail‑Order, and 90‑Day Supplies

Where you fill your prescription — a local retail pharmacy, a mail‑order service, or a 90‑day supply — affects both cost and convenience. Retail purchases of brand Eliquis can exceed $388 for about 28 tablets without insurance, while mail‑order and PBM channels often reduce the per‑tablet price. A 90‑day supply can lower costs and cut pharmacy trips, but eligibility depends on your plan’s rules. Comparing retail, mail‑order, and generic options is the best way to find savings. Coupons and copay tools sometimes help, though plan restrictions and prior authorization requirements may apply. Confirm whether your Medicare or private plan treats 90‑day fills differently before you switch pharmacies.

Option

Emotional weight

Retail

Immediate access but often more expensive

Mail-order

Lower cost, slower delivery

90-day supply

Fewer refills and potential savings, subject to plan rules

Doctor Analyzing Healthcare Costs and Financial Trends

Assistance Programs and Manufacturer Savings Strategies

If retail or mail‑order prices are still high, patients can look to assistance programs and manufacturer savings strategies. Manufacturer programs include a $10 copay card for commercial plans (valid up to 24 months with a $6,400 annual cap) and a Free Trial Offer Card; these offers exclude Medicare Part D, Medicaid, and other government plans. A patient assistance program can provide free medicine for up to 12 months to uninsured people who meet income thresholds (for example, single households up to $46,950), with reapplication options. Third‑party coupons like SingleCare may lower retail prices (about $156 for 26 tablets at some pharmacies) but also typically exclude government plans. For ongoing savings, combine eligible assistance programs with 90‑day supplies, mail‑order options, and price comparisons across pharmacies.

Comparing Apixaban to Cheaper Anticoagulant Alternatives

Apixaban generally costs more than warfarin but requires less monitoring and has fewer dietary restrictions. Generic apixaban pricing narrows that gap, with per‑tablet rates around $1.08–$1.50 through discount services. Warfarin’s drug cost is lower (about $28 for thirty 5 mg tablets), but its savings can be offset by routine INR testing and management. Insurance coverage, Medicare Part D rules, Medicaid, 90‑day mail‑order fills, and assistance programs all shape final out‑of‑pocket costs and should factor into treatment and cost decisions.

Factor

Implication

Drug price

Warfarin cheaper; generic apixaban lowers cost gap

Monitoring

Warfarin requires frequent INR checks

Convenience

Apixaban preferred when you want no routine testing

Insurance impact

Coverage varies; copays differ by plan

Savings tactics

90‑day fills, coupons, and assistance programs can help

Frequently Asked Questions

Is ELIQUIS going to be free in 2026?

No — Eliquis is unlikely to be free in 2026. Costs will still depend on your insurance, Medicare rules, manufacturer programs, and eligibility for patient assistance, so check your coverage and available savings for your situation.

How much is apixaban in the United States?

Prices vary: with insurance many people pay roughly $37–$51 per month (many pay $20–$30), while uninsured retail costs can exceed $388–$800 for short supplies. Discounts, generics, and assistance programs can substantially lower out‑of‑pocket expenses.

Is generic apixaban available yet?

No — generic apixaban is not available in the United States yet. Availability is expected no earlier than April 1, 2028. Check with your insurer and pharmacy for the latest coverage and pricing updates.

How much will ELIQUIS cost next year?

It’s hard to predict. Next year’s cost will vary by plan, pharmacy, and available discounts. Many people with insurance will likely pay roughly $30–$50 per month; some eligible for subsidies may pay $0–$12, while uninsured patients may face substantially higher prices.

Count on https://drugmart.com When You Need to Import Prescription Drugs Through Canada When you work with https://drugmart.com, ordering medicine through Canada is easy, safe and cost-effective. You can rely on our reputable network of pharmacies to deliver the authentic drugs you need. If you're ready to import prescription drugs through Canada and our other verified international pharmacies, you can start today by browsing our available medications.


Sources

  1. Okafor, C., Byrnes, J., Stewart, S., Scuffham, P., & Afoakwah, C. (2023). Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review. Pharmacoeconomics, 41(8), 913–943. https://link.springer.com/article/10.1007/s40273-023-01276-5

  2. Waldron, B. (2022). Nonmedical switching of anticoagulants: The patient impact when formulary exclusions limit drug choice. Research and Practice in Thrombosis and Haemostasis, 6(2), e12675. https://www.rpthjournal.org/article/S2475-0379(22)01166-9/fulltext

  3. Clemans-Cope, L., Epstein, M., Banthin, J. S., Kesselheim, A. S., & Hwang, T. J. (2023). Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019. Jama Health Forum, 4(1), e225012. https://jamanetwork.com/journals/jama-health-forum/fullarticle/2800317


Related Articles


The content on this page is for informational and educational purposes only and does not constitute professional medical advice. Patients should not use the information presented on this page for diagnosing a health-related issue or disease. Before taking any medication or supplements, patients should always consult a physician or qualified healthcare professional for medical advice or information about whether a drug is safe, appropriate or effective.